ES2054147T3 - Utilizacion de naftopidil para la terapia de la disuria en el caso de hipertrofia benigna de la prostata. - Google Patents

Utilizacion de naftopidil para la terapia de la disuria en el caso de hipertrofia benigna de la prostata.

Info

Publication number
ES2054147T3
ES2054147T3 ES90110207T ES90110207T ES2054147T3 ES 2054147 T3 ES2054147 T3 ES 2054147T3 ES 90110207 T ES90110207 T ES 90110207T ES 90110207 T ES90110207 T ES 90110207T ES 2054147 T3 ES2054147 T3 ES 2054147T3
Authority
ES
Spain
Prior art keywords
dysuria
prostate
naftopidil
therapy
case
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90110207T
Other languages
English (en)
Spanish (es)
Inventor
Gisbert Dr Med Vet Sponer
Ulrich Reicke
Michael Dr Nelbock-Hochstetter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6382247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2054147(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2054147T3 publication Critical patent/ES2054147T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ES90110207T 1989-06-07 1990-05-30 Utilizacion de naftopidil para la terapia de la disuria en el caso de hipertrofia benigna de la prostata. Expired - Lifetime ES2054147T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918543A DE3918543A1 (de) 1989-06-07 1989-06-07 Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie

Publications (1)

Publication Number Publication Date
ES2054147T3 true ES2054147T3 (es) 1994-08-01

Family

ID=6382247

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90110207T Expired - Lifetime ES2054147T3 (es) 1989-06-07 1990-05-30 Utilizacion de naftopidil para la terapia de la disuria en el caso de hipertrofia benigna de la prostata.

Country Status (19)

Country Link
US (1) US5026706A (esLanguage)
EP (1) EP0401653B1 (esLanguage)
JP (1) JPH062673B2 (esLanguage)
KR (1) KR0131452B1 (esLanguage)
AT (1) ATE84416T1 (esLanguage)
AU (1) AU625766B2 (esLanguage)
CA (1) CA2017619C (esLanguage)
DD (1) DD294864A5 (esLanguage)
DE (2) DE3918543A1 (esLanguage)
DK (1) DK0401653T3 (esLanguage)
ES (1) ES2054147T3 (esLanguage)
GR (1) GR3007328T3 (esLanguage)
HK (1) HK46996A (esLanguage)
HU (1) HU206976B (esLanguage)
IE (1) IE62937B1 (esLanguage)
IL (1) IL94601A (esLanguage)
PH (1) PH26690A (esLanguage)
PT (1) PT94268B (esLanguage)
ZA (1) ZA904338B (esLanguage)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
EP1832598A3 (en) 1999-09-30 2008-01-02 Hollis-Eden Pharmaceuticals Inc. Therapeutic treatment of androgen receptor driven conditions
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
BR102012000187A2 (pt) * 2012-01-05 2018-04-10 Univ Rio De Janeiro Derivados n-fenilpiperazínicos antagonistas de adrenoceptores a1a, a1d e de receptores 5-ht1a no tratamento da hiperplasia prostática benigna, composições farmacêuticas contendo os mesmos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.

Also Published As

Publication number Publication date
HUT54494A (en) 1991-03-28
IL94601A0 (en) 1991-04-15
GR3007328T3 (esLanguage) 1993-07-30
DD294864A5 (de) 1991-10-17
DE3918543C2 (esLanguage) 1991-06-06
PT94268B (pt) 1997-01-31
KR910000152A (ko) 1991-01-29
DK0401653T3 (da) 1993-03-29
ATE84416T1 (de) 1993-01-15
ZA904338B (en) 1991-03-27
EP0401653B1 (de) 1993-01-13
CA2017619C (en) 1995-06-20
PH26690A (en) 1992-09-15
DE59000748D1 (de) 1993-02-25
JPH0324014A (ja) 1991-02-01
JPH062673B2 (ja) 1994-01-12
IE62937B1 (en) 1995-03-08
PT94268A (pt) 1991-02-08
IE902014L (en) 1990-12-07
HK46996A (en) 1996-03-22
KR0131452B1 (ko) 1998-04-17
AU5628290A (en) 1990-12-13
IL94601A (en) 1994-06-24
DE3918543A1 (de) 1990-12-13
EP0401653A3 (de) 1991-07-17
AU625766B2 (en) 1992-07-16
CA2017619A1 (en) 1990-12-07
HU206976B (en) 1993-03-01
HU903515D0 (en) 1990-10-28
US5026706A (en) 1991-06-25
EP0401653A2 (de) 1990-12-12

Similar Documents

Publication Publication Date Title
CL2012002380A1 (es) Compuestos derivados de bezoimidazol, inhibidores de mek; utiles en el tratamiento del cancer.(divisional solicitud cl 521-03)
NO975716L (no) Imidazolforbindelser
ES519637A0 (es) Mejoras introducidas en vendas de escayolado ortopedico.
PT804196E (pt) Utilizacao de antagonistas de serotonina (5ht3) para o tratamento de fibromialgia
ES502538A0 (es) Maquina portatil para el calculo o el tratamiento de la in- formacion
IT8819158A0 (it) Riscaldatore perfezionato da usare come sorgente di calore primaria o ausiliaria e circuiteria perfezionata per il controllo del riscaldatore.
AR010348A1 (es) Cetobenzamidas, su utilizacion y composicion farmeceutica que las contienen
ES2182906T3 (es) Grapa quirurgica helicoidal.
UY25242A1 (es) Inhibidores de benzotiazol de la proteína tirosina cinasa
ES2184127T3 (es) Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad.
ES2146886T3 (es) Inhibidores de la selectina de moleculas pequeñas bivalentes y trivalentes.
ES2179096T3 (es) Utilizacion de la interleucina-12 para prevenir la reaccion del injerto contra el huesped.
AR012626A1 (es) Una composicion farmaeutica que comprende un derivado o análogo de leptina como inhibidor de la proliferacion de células de tumor y el uso de dicha composicion farmaceutica para la manufactura de medicamento para el tratamiento de tumores
AR016981A2 (es) Polipeptidos sinteticos
ES2054147T3 (es) Utilizacion de naftopidil para la terapia de la disuria en el caso de hipertrofia benigna de la prostata.
DE68915503D1 (de) Zahnchirurgisches Gerät, geeignet für die Versorgung von gekoppelten Handstücken mit drei unterschiedlichen Fluida.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
TR200101693T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
ES2134184T3 (es) Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica.
ES2065307T3 (es) Producto y procedimiento para el moldeado permanente del cabello.
ES492195A0 (es) Clavo elastico para la reduccion de fractura de trocanter e implantacion que utiliza este clavo elastico
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
ES2165233T3 (es) Empleo de 1-fosfato de esfingosina, derivados de 1-fosfato de esfingosina y/o sus mezclas para el tratamiento de enfermedades cutaneas inflamatorias.
DE69930844D1 (de) Inhibitoren von mycobakterien
ATE69549T1 (de) Erzeugnisse, enthaltend gallopamil und prazosin.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 401653

Country of ref document: ES